Last Updated : October 23, 2018
Details
FilesGeneric Name:
Riociguat
Project Status:
Complete
Therapeutic Area:
Pulmonary arterial hypertension (WHO group 1)
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Adempas
Project Line:
Reimbursement Review
Project Number:
SR0438-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Pulmonary arterial hypertension (WHO group 1)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : October 23, 2018